rethinkPeptides Search
Menu
Research citation

Probing for peptidic drugs (2-10 kDa) in doping control blood samples.

evidence

This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.

What the researchers found

The method successfully detected multiple peptides in blood samples, fulfilling WADA requirements.

Why it matters

This research is significant for improving doping control in sports, ensuring fair competition. It provides a reliable method for detecting banned substances that are increasingly used by athletes.

How the study worked

The study employed liquid chromatography coupled with high-resolution mass spectrometry for peptide analysis in blood samples.

What this study cannot tell us

The study primarily focuses on blood samples and may not address urine testing or other sample types.

Read the original research

Probing for peptidic drugs (2-10 kDa) in doping control blood samples.

Analytical science advances, 3(7-8), 235-243

Citation

Thomas, Andreas; Thilmany, Sam; Hofmann, Amelie; Thevis, Mario. (2022). Probing for peptidic drugs (2-10 kDa) in doping control blood samples.. Analytical science advances, 3(7-8), 235-243. https://doi.org/10.1002/ansa.202200027